88IV - Public company info - Lepu Biopharma Co. Ltd. -H Shares

Input the stock code or the company name

Lepu Biopharma Co. Ltd. -H Shares, 02157.HK - Cash Flow	2021-12	2020-12	2019-12
Net Cash Flow from Operating Activities	-626,189	-427,919	-234,390
Net Cash Flow from Return on Investments & Servicing of Finance	-4,838	-7,465	-297
Interest Received	4,453	5,230	396
Interest Paid	-9,291	-12,695	-693
Dividend Received	0	0	0
Dividend Paid	0	0	0
Others	0	0	0
Taxes (Paid) / Refunded	0	0	0
Net Cash Flow from Investing Activities	-3,892	-749,669	-415,318
Additions to Fixed Assets	-213,385	-293,873	-318,471
Disposal of Fixed Assets	0	771	0
Increase in Investments	-1,129,001	-1,702,175	-519,500
Decrease in Investments	1,474,610	1,332,701	511,535
Net Cash Flow with Related Parties	261,120	1,394,500	296,390
Others	-397,236	-1,481,593	-385,272
Net Cash Flow before Financing Activities	-634,919	-1,185,053	-650,005
Net Cash Flow from Financing Activities	389,601	1,399,374	771,087
New Loans	146,112	59,000	118,266
Loans Repayment	-15,815	-54,126	-1,685
Fixed Income/Debt Instruments	0	0	358,116
Repayment of Fixed Income/Debt Instruments	0	0	0
Equity Financing	0	0	0
Net Cash Flow with Related Parties	261,120	1,394,500	296,390
Others	-1,816	0	0
Increase(Decrease) in Cash & Cash Equivalents	-245,318	214,321	121,082
Cash & Cash Equivalents at Beginning of Year	402,867	188,545	67,462
Net Cash Flow due to Change in Exchange Rate/Others	-2,381	1	1
Cash & Cash Equivalents at End of Year	155,168	402,867	188,545
Currency	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Lepu Biopharma Co. Ltd. -H Shares , 02157.HK